Shaun O’Brien

Bristol-Myers Squibb (Germany)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 5 papers. Top paper: “Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors”.

Phase I study of BMS-986299, an NLRP3 agonist, as monotherapy and in combination with nivolumab and ipilimumab in patients with advanced solid tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010013

N/A

0.617DataRank · unranked

22 citations

Shaun O’Brien, Rahul A. Sheth, David S. Hong, Aung Naing, Xiao–Ping Zhang +7 more

Identification and characterization of tissue resident memory T cells in malignant pleural effusions associated with non-small cell lung cancer

ImmunoHorizons(2025)10.1093/immhor/vlaf013

N/A

0.330DataRank · unranked

8 citations

Joshua Brotman, Shaun O’Brien, Brennan Lee, Edmund Moon, Steven M Albelda +1 more

Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity

Molecular Therapy(2020)10.1016/j.ymthe.2020.11.001

N/A

0DataRank · unranked

35 citations

Andrew R. Haas, Marina C. Martinez, Shaun O’Brien, Edmund K. Moon, Patrick Woodruff +14 more

592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0592

N/A

0DataRank · unranked

2 citations

Richard D. Carvajal, Diwakar Davar, Eduardo Castañón, Paolo A. Ascierto, Emiliano Calvo +16 more

Nonredundant Immune Checkpoints Direct Therapeutic Resistance to Chemoimmunotherapy in Pancreatic Ductal Adenocarcinoma

Cancer Immunology Research(2025)10.1158/2326-6066.cir-25-0575

N/A

0DataRank · unranked

2 citations

Veronica M. Herrera, Yan Li, Heather Coho, Yuqing Xue, Kathleen Graham +5 more